MX2011004002A

MX2011004002A - Polipeptidos transducibles para modificar el metabolismo mitocondrico.

Polipeptidos transducibles para modificar el metabolismo mitocondrico.

Info

Publication number: MX2011004002A
Authority: MX; Mexico
Prior art keywords: protein; domain; mitochondrial; cell; antibody
Prior art date: 2008-10-16

Application number

MX2011004002A

Other languages

English (en)

Spanish (es)

Inventor

Shaharyar Khan

Original Assignee

Gencia Corp

Priority date

2008-10-16

Filing date

2009-10-14

Publication date

2011-06-20

2009-10-14 Application filed by Gencia Corp filed Critical Gencia Corp

2011-06-20 Publication of MX2011004002A publication Critical patent/MX2011004002A/es

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 125
102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 114
229920001184 polypeptide Polymers 0.000 title claims abstract description 113
230000006677 mitochondrial metabolism Effects 0.000 title description 3
108090000623 proteins and genes Proteins 0.000 claims abstract description 97
102000004169 proteins and genes Human genes 0.000 claims abstract description 87
102000040430 polynucleotide Human genes 0.000 claims abstract description 79
108091033319 polynucleotide Proteins 0.000 claims abstract description 79
239000002157 polynucleotide Substances 0.000 claims abstract description 79
230000027455 binding Effects 0.000 claims abstract description 60
239000000203 mixture Substances 0.000 claims abstract description 56
230000008685 targeting Effects 0.000 claims abstract description 29
230000026683 transduction Effects 0.000 claims abstract description 13
238000010361 transduction Methods 0.000 claims abstract description 13
210000004027 cell Anatomy 0.000 claims description 115
150000001413 amino acids Chemical group 0.000 claims description 47
230000002438 mitochondrial effect Effects 0.000 claims description 31
239000000427 antigen Substances 0.000 claims description 24
102000036639 antigens Human genes 0.000 claims description 24
101000835023 Homo sapiens Transcription factor A, mitochondrial Proteins 0.000 claims description 23
108091007433 antigens Proteins 0.000 claims description 23
102100026155 Transcription factor A, mitochondrial Human genes 0.000 claims description 22
239000012634 fragment Substances 0.000 claims description 19
239000003446 ligand Substances 0.000 claims description 16
238000006467 substitution reaction Methods 0.000 claims description 13
102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 8
108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 8
230000008437 mitochondrial biogenesis Effects 0.000 claims description 8
230000010415 tropism Effects 0.000 claims description 7
101710160107 Outer membrane protein A Proteins 0.000 claims description 6
239000004094 surface-active agent Substances 0.000 claims description 4
108090001090 Lectins Proteins 0.000 claims description 3
102000004856 Lectins Human genes 0.000 claims description 3
230000037396 body weight Effects 0.000 claims description 3
102000037865 fusion proteins Human genes 0.000 claims description 3
108020001507 fusion proteins Proteins 0.000 claims description 3
239000002523 lectin Substances 0.000 claims description 3
108010045576 mitochondrial transcription factor A Proteins 0.000 claims description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 2
102000015215 Stem Cell Factor Human genes 0.000 claims description 2
108010039445 Stem Cell Factor Proteins 0.000 claims description 2
102000004338 Transferrin Human genes 0.000 claims description 2
108090000901 Transferrin Proteins 0.000 claims description 2
101800004564 Transforming growth factor alpha Proteins 0.000 claims description 2
102400001320 Transforming growth factor alpha Human genes 0.000 claims description 2
230000003302 anti-idiotype Effects 0.000 claims description 2
230000001262 anti-secretory effect Effects 0.000 claims description 2
210000001367 artery Anatomy 0.000 claims description 2
229940014144 folate Drugs 0.000 claims description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 2
235000019152 folic acid Nutrition 0.000 claims description 2
239000011724 folic acid Substances 0.000 claims description 2
239000012581 transferrin Substances 0.000 claims description 2
108010077805 Bacterial Proteins Proteins 0.000 claims 4
230000004927 fusion Effects 0.000 claims 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims 1
108010002913 Asialoglycoproteins Proteins 0.000 claims 1
102000004877 Insulin Human genes 0.000 claims 1
108090001061 Insulin Proteins 0.000 claims 1
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 1
108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 claims 1
238000000338 in vitro Methods 0.000 claims 1
238000001727 in vivo Methods 0.000 claims 1
229940125396 insulin Drugs 0.000 claims 1
238000000034 method Methods 0.000 abstract description 28
230000004060 metabolic process Effects 0.000 abstract description 6
235000018102 proteins Nutrition 0.000 description 80
235000001014 amino acid Nutrition 0.000 description 46
229940024606 amino acid Drugs 0.000 description 45
210000003463 organelle Anatomy 0.000 description 34
210000003470 mitochondria Anatomy 0.000 description 27
108020004414 DNA Proteins 0.000 description 21
239000012528 membrane Substances 0.000 description 21
102000005962 receptors Human genes 0.000 description 21
108020003175 receptors Proteins 0.000 description 20
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
238000009472 formulation Methods 0.000 description 16
201000010099 disease Diseases 0.000 description 14
230000006870 function Effects 0.000 description 14
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 13
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
108020005196 Mitochondrial DNA Proteins 0.000 description 12
210000003763 chloroplast Anatomy 0.000 description 12
108010033040 Histones Proteins 0.000 description 11
206010028980 Neoplasm Diseases 0.000 description 11
150000001720 carbohydrates Chemical group 0.000 description 11
235000005772 leucine Nutrition 0.000 description 11
210000001519 tissue Anatomy 0.000 description 11
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 10
102000040945 Transcription factor Human genes 0.000 description 10
108091023040 Transcription factor Proteins 0.000 description 10
235000014633 carbohydrates Nutrition 0.000 description 10
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 9
241000699670 Mus sp. Species 0.000 description 9
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 9
230000001965 increasing effect Effects 0.000 description 9
230000029058 respiratory gaseous exchange Effects 0.000 description 9
239000011701 zinc Substances 0.000 description 9
229910052725 zinc Inorganic materials 0.000 description 9
108010048671 Homeodomain Proteins Proteins 0.000 description 8
102000009331 Homeodomain Proteins Human genes 0.000 description 8
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 8
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
230000007812 deficiency Effects 0.000 description 8
102000039446 nucleic acids Human genes 0.000 description 8
108020004707 nucleic acids Proteins 0.000 description 8
150000007523 nucleic acids Chemical class 0.000 description 8
239000003981 vehicle Substances 0.000 description 8
230000004568 DNA-binding Effects 0.000 description 7
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
235000009697 arginine Nutrition 0.000 description 7
201000011510 cancer Diseases 0.000 description 7
239000000539 dimer Substances 0.000 description 7
230000003993 interaction Effects 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
208000011580 syndromic disease Diseases 0.000 description 7
239000013598 vector Substances 0.000 description 7
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
206010011878 Deafness Diseases 0.000 description 6
208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 description 6
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
201000000639 Leber hereditary optic neuropathy Diseases 0.000 description 6
125000003275 alpha amino acid group Chemical group 0.000 description 6
210000004556 brain Anatomy 0.000 description 6
235000018417 cysteine Nutrition 0.000 description 6
239000003937 drug carrier Substances 0.000 description 6
230000002209 hydrophobic effect Effects 0.000 description 6
150000002632 lipids Chemical class 0.000 description 6
230000004898 mitochondrial function Effects 0.000 description 6
239000008194 pharmaceutical composition Substances 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 5
239000004475 Arginine Substances 0.000 description 5
208000031229 Cardiomyopathies Diseases 0.000 description 5
102000014914 Carrier Proteins Human genes 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
208000021642 Muscular disease Diseases 0.000 description 5
201000009623 Myopathy Diseases 0.000 description 5
208000009869 Neu-Laxova syndrome Diseases 0.000 description 5
108010077850 Nuclear Localization Signals Proteins 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
230000004075 alteration Effects 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
235000021050 feed intake Nutrition 0.000 description 5
230000014509 gene expression Effects 0.000 description 5
239000008103 glucose Substances 0.000 description 5
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
235000004554 glutamine Nutrition 0.000 description 5
208000016354 hearing loss disease Diseases 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
230000003834 intracellular effect Effects 0.000 description 5
210000003205 muscle Anatomy 0.000 description 5
210000000663 muscle cell Anatomy 0.000 description 5
210000000653 nervous system Anatomy 0.000 description 5
239000000546 pharmaceutical excipient Substances 0.000 description 5
230000000750 progressive effect Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
210000002377 thylakoid Anatomy 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
108091026890 Coding region Proteins 0.000 description 4
201000002650 Ellis-van Creveld syndrome Diseases 0.000 description 4
239000004471 Glycine Substances 0.000 description 4
102100037907 High mobility group protein B1 Human genes 0.000 description 4
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
208000035177 MELAS Diseases 0.000 description 4
208000008589 Obesity Diseases 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
235000004279 alanine Nutrition 0.000 description 4
-1 antibodies Proteins 0.000 description 4
235000009582 asparagine Nutrition 0.000 description 4
229960001230 asparagine Drugs 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
108091008324 binding proteins Proteins 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
231100000895 deafness Toxicity 0.000 description 4
206010012601 diabetes mellitus Diseases 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
239000002270 dispersing agent Substances 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
239000002207 metabolite Substances 0.000 description 4
208000012268 mitochondrial disease Diseases 0.000 description 4
230000004065 mitochondrial dysfunction Effects 0.000 description 4
239000000178 monomer Substances 0.000 description 4
230000036457 multidrug resistance Effects 0.000 description 4
230000003472 neutralizing effect Effects 0.000 description 4
235000020824 obesity Nutrition 0.000 description 4
239000007800 oxidant agent Substances 0.000 description 4
230000001590 oxidative effect Effects 0.000 description 4
230000010627 oxidative phosphorylation Effects 0.000 description 4
238000007911 parenteral administration Methods 0.000 description 4
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
210000003705 ribosome Anatomy 0.000 description 4
239000003381 stabilizer Substances 0.000 description 4
230000014616 translation Effects 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
208000024827 Alzheimer disease Diseases 0.000 description 3
108700031308 Antennapedia Homeodomain Proteins 0.000 description 3
108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 3
102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 3
102100023995 Beta-nerve growth factor Human genes 0.000 description 3
208000014644 Brain disease Diseases 0.000 description 3
201000009030 Carcinoma Diseases 0.000 description 3
102000052510 DNA-Binding Proteins Human genes 0.000 description 3
108700020911 DNA-Binding Proteins Proteins 0.000 description 3
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
208000032274 Encephalopathy Diseases 0.000 description 3
208000015872 Gaucher disease Diseases 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
108010025020 Nerve Growth Factor Proteins 0.000 description 3
206010033128 Ovarian cancer Diseases 0.000 description 3
208000018737 Parkinson disease Diseases 0.000 description 3
101710149951 Protein Tat Proteins 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
101710106660 Shutoff alkaline exonuclease Proteins 0.000 description 3
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
239000004473 Threonine Substances 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
206010015037 epilepsy Diseases 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
235000012631 food intake Nutrition 0.000 description 3
210000003494 hepatocyte Anatomy 0.000 description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
230000008676 import Effects 0.000 description 3
229960000310 isoleucine Drugs 0.000 description 3
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
239000000463 material Substances 0.000 description 3
201000001441 melanoma Diseases 0.000 description 3
229930182817 methionine Natural products 0.000 description 3
210000001700 mitochondrial membrane Anatomy 0.000 description 3
230000025608 mitochondrion localization Effects 0.000 description 3
229940053128 nerve growth factor Drugs 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
230000004783 oxidative metabolism Effects 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000000241 respiratory effect Effects 0.000 description 3
239000002904 solvent Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000000375 suspending agent Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
239000000080 wetting agent Substances 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
RAVVEEJGALCVIN-AGVBWZICSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-(diamino Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RAVVEEJGALCVIN-AGVBWZICSA-N 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
102100023635 Alpha-fetoprotein Human genes 0.000 description 2
208000003343 Antiphospholipid Syndrome Diseases 0.000 description 2
101100178203 Arabidopsis thaliana HMGB3 gene Proteins 0.000 description 2
239000000592 Artificial Cell Substances 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
206010003591 Ataxia Diseases 0.000 description 2
201000001320 Atherosclerosis Diseases 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
208000011691 Burkitt lymphomas Diseases 0.000 description 2
108010074051 C-Reactive Protein Proteins 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
206010058892 Carnitine deficiency Diseases 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
108010051109 Cell-Penetrating Peptides Proteins 0.000 description 2
102000020313 Cell-Penetrating Peptides Human genes 0.000 description 2
201000006082 Chickenpox Diseases 0.000 description 2
108010077544 Chromatin Proteins 0.000 description 2
201000000915 Chronic Progressive External Ophthalmoplegia Diseases 0.000 description 2
208000010200 Cockayne syndrome Diseases 0.000 description 2
208000011231 Crohn disease Diseases 0.000 description 2
102100026398 Cyclic AMP-responsive element-binding protein 3 Human genes 0.000 description 2
206010058314 Dysplasia Diseases 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
208000007698 Gyrate Atrophy Diseases 0.000 description 2
101150091750 HMG1 gene Proteins 0.000 description 2
108700010013 HMGB1 Proteins 0.000 description 2
101150021904 HMGB1 gene Proteins 0.000 description 2
102000018802 High Mobility Group Proteins Human genes 0.000 description 2
108010052512 High Mobility Group Proteins Proteins 0.000 description 2
101710168537 High mobility group protein B1 Proteins 0.000 description 2
102100022128 High mobility group protein B2 Human genes 0.000 description 2
108700005087 Homeobox Genes Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000855520 Homo sapiens Cyclic AMP-responsive element-binding protein 3 Proteins 0.000 description 2
101001045791 Homo sapiens High mobility group protein B2 Proteins 0.000 description 2
101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
108700000788 Human immunodeficiency virus 1 tat peptide (47-57) Proteins 0.000 description 2
108700003968 Human immunodeficiency virus 1 tat peptide (49-57) Proteins 0.000 description 2
208000010038 Ischemic Optic Neuropathy Diseases 0.000 description 2
206010024229 Leprosy Diseases 0.000 description 2
208000010994 Lethal infantile mitochondrial myopathy Diseases 0.000 description 2
239000000232 Lipid Bilayer Substances 0.000 description 2
208000035172 MERRF Diseases 0.000 description 2
208000014413 Maternally-inherited diabetes and deafness Diseases 0.000 description 2
108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
108700021610 Mitochondrial Precursor Protein Import Complex Proteins Proteins 0.000 description 2
208000005647 Mumps Diseases 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
241000699660 Mus musculus Species 0.000 description 2
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 2
206010029260 Neuroblastoma Diseases 0.000 description 2
102000004108 Neurotransmitter Receptors Human genes 0.000 description 2
108090000590 Neurotransmitter Receptors Proteins 0.000 description 2
208000014060 Niemann-Pick disease Diseases 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
102000043276 Oncogene Human genes 0.000 description 2
206010030924 Optic ischaemic neuropathy Diseases 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
206010061902 Pancreatic neoplasm Diseases 0.000 description 2
201000005702 Pertussis Diseases 0.000 description 2
241000097929 Porphyria Species 0.000 description 2
208000010642 Porphyrias Diseases 0.000 description 2
102000007066 Prostate-Specific Antigen Human genes 0.000 description 2
108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
241000700157 Rattus norvegicus Species 0.000 description 2
208000005587 Refsum Disease Diseases 0.000 description 2
208000006289 Rett Syndrome Diseases 0.000 description 2
102100038583 Secreted Ly-6/uPAR-related protein 1 Human genes 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
208000034972 Sudden Infant Death Diseases 0.000 description 2
206010042440 Sudden infant death syndrome Diseases 0.000 description 2
102100034204 Transcription factor SOX-9 Human genes 0.000 description 2
102100035559 Transcriptional activator GLI3 Human genes 0.000 description 2
208000004938 Trematode Infections Diseases 0.000 description 2
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
206010046980 Varicella Diseases 0.000 description 2
101710185494 Zinc finger protein Proteins 0.000 description 2
102100023597 Zinc finger protein 816 Human genes 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000008186 active pharmaceutical agent Substances 0.000 description 2
238000007792 addition Methods 0.000 description 2
208000030597 adult Refsum disease Diseases 0.000 description 2
230000032683 aging Effects 0.000 description 2
108010026331 alpha-Fetoproteins Proteins 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
239000008135 aqueous vehicle Substances 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
229940009098 aspartate Drugs 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000008827 biological function Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
230000030833 cell death Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
229930002875 chlorophyll Natural products 0.000 description 2
235000019804 chlorophyll Nutrition 0.000 description 2
ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
210000003483 chromatin Anatomy 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
150000001945 cysteines Chemical class 0.000 description 2
238000011161 development Methods 0.000 description 2
238000006471 dimerization reaction Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
206010014881 enterobiasis Diseases 0.000 description 2
208000028104 epidemic louse-borne typhus Diseases 0.000 description 2
235000013305 food Nutrition 0.000 description 2
229930182830 galactose Chemical group 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
229930195712 glutamate Natural products 0.000 description 2
210000002216 heart Anatomy 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
206010020871 hypertrophic cardiomyopathy Diseases 0.000 description 2
206010022000 influenza Diseases 0.000 description 2
239000007972 injectable composition Substances 0.000 description 2
150000002484 inorganic compounds Chemical class 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
210000005229 liver cell Anatomy 0.000 description 2
230000004807 localization Effects 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
208000010805 mumps infectious disease Diseases 0.000 description 2
230000035772 mutation Effects 0.000 description 2
210000002569 neuron Anatomy 0.000 description 2
239000002858 neurotransmitter agent Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
239000003921 oil Substances 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
201000002528 pancreatic cancer Diseases 0.000 description 2
208000008443 pancreatic carcinoma Diseases 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
108010043655 penetratin Proteins 0.000 description 2
MCYTYTUNNNZWOK-LCLOTLQISA-N penetratin Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 MCYTYTUNNNZWOK-LCLOTLQISA-N 0.000 description 2
230000000243 photosynthetic effect Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 2
208000004441 taeniasis Diseases 0.000 description 2
231100000607 toxicokinetics Toxicity 0.000 description 2
239000004474 valine Substances 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
238000001262 western blot Methods 0.000 description 2
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
206010001513 AIDS related complex Diseases 0.000 description 1
102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
206010063409 Acarodermatitis Diseases 0.000 description 1
208000000230 African Trypanosomiasis Diseases 0.000 description 1
208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
208000023434 Alpers-Huttenlocher syndrome Diseases 0.000 description 1
208000024985 Alport syndrome Diseases 0.000 description 1
208000004881 Amebiasis Diseases 0.000 description 1
206010001935 American trypanosomiasis Diseases 0.000 description 1
206010001980 Amoebiasis Diseases 0.000 description 1
206010001981 Amoebic infections Diseases 0.000 description 1
208000009575 Angelman syndrome Diseases 0.000 description 1
241000219195 Arabidopsis thaliana Species 0.000 description 1
102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 1
206010003594 Ataxia telangiectasia Diseases 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 1
102000019260 B-Cell Antigen Receptors Human genes 0.000 description 1
108010012919 B-Cell Antigen Receptors Proteins 0.000 description 1
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
208000004429 Bacillary Dysentery Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
201000005943 Barth syndrome Diseases 0.000 description 1
108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
230000005653 Brownian motion process Effects 0.000 description 1
206010006500 Brucellosis Diseases 0.000 description 1
206010069748 Burkholderia pseudomallei infection Diseases 0.000 description 1
102100032912 CD44 antigen Human genes 0.000 description 1
241000244203 Caenorhabditis elegans Species 0.000 description 1
101000823934 Caenorhabditis elegans Serine palmitoyltransferase 3 Proteins 0.000 description 1
101100489922 Caenorhabditis elegans abf-2 gene Proteins 0.000 description 1
206010051226 Campylobacter infection Diseases 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical class O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
208000020446 Cardiac disease Diseases 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
208000003732 Cat-scratch disease Diseases 0.000 description 1
206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 1
208000024699 Chagas disease Diseases 0.000 description 1
208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
101000986346 Chironomus tentans High mobility group protein I Proteins 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
206010008723 Chondrodystrophy Diseases 0.000 description 1
102000010792 Chromogranin A Human genes 0.000 description 1
108010038447 Chromogranin A Proteins 0.000 description 1
206010008909 Chronic Hepatitis Diseases 0.000 description 1
208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
206010009344 Clonorchiasis Diseases 0.000 description 1
108010073254 Colicins Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
208000009802 Colorado tick fever Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
208000008448 Congenital adrenal hyperplasia Diseases 0.000 description 1
206010062344 Congenital musculoskeletal anomaly Diseases 0.000 description 1
208000008953 Cryptosporidiosis Diseases 0.000 description 1
206010011502 Cryptosporidiosis infection Diseases 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
201000000077 Cysticercosis Diseases 0.000 description 1
102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
208000002155 Cytochrome-c Oxidase Deficiency Diseases 0.000 description 1
108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
206010011831 Cytomegalovirus infection Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
208000001490 Dengue Diseases 0.000 description 1
206010012310 Dengue fever Diseases 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
208000004986 Diffuse Cerebral Sclerosis of Schilder Diseases 0.000 description 1
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
206010013883 Dwarfism Diseases 0.000 description 1
208000014094 Dystonic disease Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
208000030820 Ebola disease Diseases 0.000 description 1
102000015782 Electron Transport Complex III Human genes 0.000 description 1
108010024882 Electron Transport Complex III Proteins 0.000 description 1
206010014612 Encephalitis viral Diseases 0.000 description 1
208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
206010014979 Epidemic typhus Diseases 0.000 description 1
201000006353 Filariasis Diseases 0.000 description 1
208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
241000710198 Foot-and-mouth disease virus Species 0.000 description 1
208000024412 Friedreich ataxia Diseases 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
102100028652 Gamma-enolase Human genes 0.000 description 1
206010017918 Gastroenteritis viral Diseases 0.000 description 1
206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
208000007465 Giant cell arteritis Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
208000000807 Gnathostomiasis Diseases 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
208000003807 Graves Disease Diseases 0.000 description 1
208000015023 Graves' disease Diseases 0.000 description 1
108700010012 HMGN1 Proteins 0.000 description 1
206010061192 Haemorrhagic fever Diseases 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
206010019755 Hepatitis chronic active Diseases 0.000 description 1
108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
208000033981 Hereditary haemochromatosis Diseases 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
101000698001 Homo sapiens Transcription initiation protein SPT3 homolog Proteins 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
208000022361 Human papillomavirus infectious disease Diseases 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
208000025500 Hutchinson-Gilford progeria syndrome Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
206010023076 Isosporiasis Diseases 0.000 description 1
206010048804 Kearns-Sayre syndrome Diseases 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
108010001831 LDL receptors Proteins 0.000 description 1
108010054278 Lac Repressors Proteins 0.000 description 1
206010023927 Lassa fever Diseases 0.000 description 1
208000028742 Leber hereditary optic neuropathy and dystonia Diseases 0.000 description 1
208000004023 Legionellosis Diseases 0.000 description 1
208000006136 Leigh Disease Diseases 0.000 description 1
208000017507 Leigh syndrome Diseases 0.000 description 1
208000004554 Leishmaniasis Diseases 0.000 description 1
206010024238 Leptospirosis Diseases 0.000 description 1
102000010954 Link domains Human genes 0.000 description 1
108050001157 Link domains Proteins 0.000 description 1
206010024641 Listeriosis Diseases 0.000 description 1
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
102100022699 Lymphoid enhancer-binding factor 1 Human genes 0.000 description 1
108090001093 Lymphoid enhancer-binding factor 1 Proteins 0.000 description 1
102100026639 MICOS complex subunit MIC60 Human genes 0.000 description 1
101710128942 MICOS complex subunit MIC60 Proteins 0.000 description 1
208000035180 MODY Diseases 0.000 description 1
206010025412 Macular dystrophy congenital Diseases 0.000 description 1
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
208000030162 Maple syrup disease Diseases 0.000 description 1
208000001826 Marfan syndrome Diseases 0.000 description 1
101710147036 Mating-type M-specific polypeptide Mc Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
241001599018 Melanogaster Species 0.000 description 1
108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
206010027202 Meningitis bacterial Diseases 0.000 description 1
206010027260 Meningitis viral Diseases 0.000 description 1
208000008948 Menkes Kinky Hair Syndrome Diseases 0.000 description 1
208000012583 Menkes disease Diseases 0.000 description 1
NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 1
208000035155 Mitochondrial DNA-associated Leigh syndrome Diseases 0.000 description 1
108010058682 Mitochondrial Proteins Proteins 0.000 description 1
102000006404 Mitochondrial Proteins Human genes 0.000 description 1
206010050029 Mitochondrial cytopathy Diseases 0.000 description 1
206010058799 Mitochondrial encephalomyopathy Diseases 0.000 description 1
201000002169 Mitochondrial myopathy Diseases 0.000 description 1
108010008699 Mucin-4 Proteins 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
101100351033 Mus musculus Pax7 gene Proteins 0.000 description 1
208000010428 Muscle Weakness Diseases 0.000 description 1
206010028372 Muscular weakness Diseases 0.000 description 1
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
208000036572 Myoclonic epilepsy Diseases 0.000 description 1
102100030856 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
208000013928 Myopathy and diabetes mellitus Diseases 0.000 description 1
201000002481 Myositis Diseases 0.000 description 1
206010068871 Myotonic dystrophy Diseases 0.000 description 1
LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
101150100316 ND4 gene Proteins 0.000 description 1
241000737052 Naso hexacanthus Species 0.000 description 1
108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 1
208000009905 Neurofibromatoses Diseases 0.000 description 1
101100386053 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cys-3 gene Proteins 0.000 description 1
101100285000 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) his-3 gene Proteins 0.000 description 1
206010029443 Nocardia Infections Diseases 0.000 description 1
206010029444 Nocardiosis Diseases 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
108010047956 Nucleosomes Proteins 0.000 description 1
241000243985 Onchocerca volvulus Species 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
101150044441 PECAM1 gene Proteins 0.000 description 1
208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 1
208000004843 Pendred Syndrome Diseases 0.000 description 1
241001442654 Percnon planissimum Species 0.000 description 1
201000011252 Phenylketonuria Diseases 0.000 description 1
102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
206010035148 Plague Diseases 0.000 description 1
208000009362 Pneumococcal Pneumonia Diseases 0.000 description 1
206010035728 Pneumonia pneumococcal Diseases 0.000 description 1
206010035737 Pneumonia viral Diseases 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
108010046644 Polymeric Immunoglobulin Receptors Proteins 0.000 description 1
208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
102000017033 Porins Human genes 0.000 description 1
108010013381 Porins Proteins 0.000 description 1
201000010769 Prader-Willi syndrome Diseases 0.000 description 1
208000007932 Progeria Diseases 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
206010037151 Psittacosis Diseases 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
206010037688 Q fever Diseases 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
101100240886 Rattus norvegicus Nptx2 gene Proteins 0.000 description 1
208000012322 Raynaud phenomenon Diseases 0.000 description 1
208000007014 Retinitis pigmentosa Diseases 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 1
101150106167 SOX9 gene Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010039438 Salmonella Infections Diseases 0.000 description 1
101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
241000447727 Scabies Species 0.000 description 1
206010039587 Scarlet Fever Diseases 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
206010040550 Shigella infections Diseases 0.000 description 1
208000021386 Sjogren Syndrome Diseases 0.000 description 1
208000001203 Smallpox Diseases 0.000 description 1
208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
208000006045 Spondylarthropathies Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
208000001106 Takayasu Arteritis Diseases 0.000 description 1
208000001163 Tangier disease Diseases 0.000 description 1
208000022292 Tay-Sachs disease Diseases 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
102100026966 Thrombomodulin Human genes 0.000 description 1
108010079274 Thrombomodulin Proteins 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
206010044269 Toxocariasis Diseases 0.000 description 1
101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 description 1
201000005485 Toxoplasmosis Diseases 0.000 description 1
102000006290 Transcription Factor TFIID Human genes 0.000 description 1
108010083268 Transcription Factor TFIID Proteins 0.000 description 1
102100030246 Transcription factor Sp1 Human genes 0.000 description 1
101710085924 Transcription factor Sp1 Proteins 0.000 description 1
102100027912 Transcription initiation protein SPT3 homolog Human genes 0.000 description 1
108010033576 Transferrin Receptors Proteins 0.000 description 1
102000007238 Transferrin Receptors Human genes 0.000 description 1
206010044608 Trichiniasis Diseases 0.000 description 1
101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
241000223109 Trypanosoma cruzi Species 0.000 description 1
208000034784 Tularaemia Diseases 0.000 description 1
206010046851 Uveitis Diseases 0.000 description 1
241000870995 Variola Species 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
206010047505 Visceral leishmaniasis Diseases 0.000 description 1
208000026724 Waardenburg syndrome Diseases 0.000 description 1
206010049644 Williams syndrome Diseases 0.000 description 1
208000018839 Wilson disease Diseases 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
208000003152 Yellow Fever Diseases 0.000 description 1
201000004525 Zellweger Syndrome Diseases 0.000 description 1
208000036813 Zellweger spectrum disease Diseases 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
208000008919 achondroplasia Diseases 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
206010064930 age-related macular degeneration Diseases 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
231100000360 alopecia Toxicity 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
201000007058 anterior ischemic optic neuropathy Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
201000009361 ascariasis Diseases 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
108010006523 asialoglycoprotein receptor Proteins 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
210000001130 astrocyte Anatomy 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
201000008680 babesiosis Diseases 0.000 description 1
201000009904 bacterial meningitis Diseases 0.000 description 1
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
230000002715 bioenergetic effect Effects 0.000 description 1
230000008436 biogenesis Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000008499 blood brain barrier function Effects 0.000 description 1
210000001218 blood-brain barrier Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
238000005537 brownian motion Methods 0.000 description 1
201000006824 bubonic plague Diseases 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
201000004927 campylobacteriosis Diseases 0.000 description 1
239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000022159 cartilage development Effects 0.000 description 1
230000032677 cell aging Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
BHONFOAYRQZPKZ-LCLOTLQISA-N chembl269478 Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=CC=C1 BHONFOAYRQZPKZ-LCLOTLQISA-N 0.000 description 1
108091000085 chlorophyll binding Proteins 0.000 description 1
230000011088 chloroplast localization Effects 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
208000014797 chronic intestinal pseudoobstruction Diseases 0.000 description 1
230000006999 cognitive decline Effects 0.000 description 1
208000010877 cognitive disease Diseases 0.000 description 1
230000007370 cognitive improvement Effects 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004590 computer program Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
201000008167 cystoisosporiasis Diseases 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
210000000172 cytosol Anatomy 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000003210 demyelinating effect Effects 0.000 description 1
208000025729 dengue disease Diseases 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
201000007394 diastrophic dysplasia Diseases 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
208000036526 difference of sexual differentiation Diseases 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
208000008576 dracunculiasis Diseases 0.000 description 1
238000009509 drug development Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
208000010118 dystonia Diseases 0.000 description 1
201000009028 early myoclonic encephalopathy Diseases 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
201000006517 essential tremor Diseases 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
208000006275 fascioliasis Diseases 0.000 description 1
206010016235 fasciolopsiasis Diseases 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
201000005206 focal segmental glomerulosclerosis Diseases 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
201000006592 giardiasis Diseases 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
201000000128 gnathomiasis Diseases 0.000 description 1
208000001786 gonorrhea Diseases 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
230000010370 hearing loss Effects 0.000 description 1
231100000888 hearing loss Toxicity 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
201000001505 hemoglobinuria Diseases 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
208000003215 hereditary nephritis Diseases 0.000 description 1
208000014188 hereditary optic neuropathy Diseases 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
208000029080 human African trypanosomiasis Diseases 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000023692 inborn mitochondrial myopathy Diseases 0.000 description 1
201000001371 inclusion conjunctivitis Diseases 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
201000006747 infectious mononucleosis Diseases 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000002687 intercalation Effects 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
210000003093 intracellular space Anatomy 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
230000001788 irregular Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
208000006443 lactic acidosis Diseases 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000002614 leucines Chemical class 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
208000028454 lice infestation Diseases 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
208000004731 long QT syndrome Diseases 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
229910001425 magnesium ion Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
208000024393 maple syrup urine disease Diseases 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
208000003531 maternally-inherited Leigh syndrome Diseases 0.000 description 1
201000006950 maturity-onset diabetes of the young Diseases 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
201000004015 melioidosis Diseases 0.000 description 1
210000000473 mesophyll cell Anatomy 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
201000001198 metagonimiasis Diseases 0.000 description 1
239000000693 micelle Substances 0.000 description 1
210000000274 microglia Anatomy 0.000 description 1
201000011540 mitochondrial DNA depletion syndrome 4a Diseases 0.000 description 1
108091064355 mitochondrial RNA Proteins 0.000 description 1
230000006705 mitochondrial oxidative phosphorylation Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
102000035118 modified proteins Human genes 0.000 description 1
108091005573 modified proteins Proteins 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
206010051747 multiple endocrine neoplasia Diseases 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
210000001665 muscle stem cell Anatomy 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
210000002346 musculoskeletal system Anatomy 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
230000002151 myoclonic effect Effects 0.000 description 1
210000004897 n-terminal region Anatomy 0.000 description 1
201000009240 nasopharyngitis Diseases 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
201000004931 neurofibromatosis Diseases 0.000 description 1
230000001272 neurogenic effect Effects 0.000 description 1
201000001119 neuropathy Diseases 0.000 description 1
230000007823 neuropathy Effects 0.000 description 1
239000002547 new drug Substances 0.000 description 1
230000000422 nocturnal effect Effects 0.000 description 1
201000002761 non-arteritic anterior ischemic optic neuropathy Diseases 0.000 description 1
210000004882 non-tumor cell Anatomy 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
229960002748 norepinephrine Drugs 0.000 description 1
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
210000001623 nucleosome Anatomy 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
230000030648 nucleus localization Effects 0.000 description 1
108010007425 oligomycin sensitivity conferring protein Proteins 0.000 description 1
208000002042 onchocerciasis Diseases 0.000 description 1
206010030875 ophthalmoplegia Diseases 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000030589 organelle localization Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
208000014380 ornithine aminotransferase deficiency Diseases 0.000 description 1
201000000901 ornithosis Diseases 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000002496 oximetry Methods 0.000 description 1
GTUJJVSZIHQLHA-XPWFQUROSA-N pApA Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@@H]1O)O[C@H](COP(O)(O)=O)[C@H]1OP(O)(=O)OC[C@H]([C@@H](O)[C@H]1O)O[C@H]1N1C(N=CN=C2N)=C2N=C1 GTUJJVSZIHQLHA-XPWFQUROSA-N 0.000 description 1
201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
108010011903 peptide receptors Proteins 0.000 description 1
125000001151 peptidyl group Chemical group 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
208000033808 peripheral neuropathy Diseases 0.000 description 1
210000002824 peroxisome Anatomy 0.000 description 1
238000002823 phage display Methods 0.000 description 1
230000029553 photosynthesis Effects 0.000 description 1
238000010672 photosynthesis Methods 0.000 description 1
239000000049 pigment Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
208000030761 polycystic kidney disease Diseases 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
208000005987 polymyositis Diseases 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000009163 protein therapy Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
229960003147 reserpine Drugs 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
206010039447 salmonellosis Diseases 0.000 description 1
208000005687 scabies Diseases 0.000 description 1
201000004409 schistosomiasis Diseases 0.000 description 1
210000004116 schwann cell Anatomy 0.000 description 1
208000023573 sensorineural hearing loss disease Diseases 0.000 description 1
230000020509 sex determination Effects 0.000 description 1
201000005113 shigellosis Diseases 0.000 description 1
230000011664 signaling Effects 0.000 description 1
201000002612 sleeping sickness Diseases 0.000 description 1
210000002807 slow-twitch muscle fiber Anatomy 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
208000002320 spinal muscular atrophy Diseases 0.000 description 1
201000005671 spondyloarthropathy Diseases 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
238000011476 stem cell transplantation Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
102000005969 steroid hormone receptors Human genes 0.000 description 1
108020003113 steroid hormone receptors Proteins 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
208000022218 streptococcal pneumonia Diseases 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000003826 tablet Substances 0.000 description 1
229960002197 temoporfin Drugs 0.000 description 1
206010043207 temporal arteritis Diseases 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000008719 thickening Effects 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
206010044325 trachoma Diseases 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011830 transgenic mouse model Methods 0.000 description 1
230000004102 tricarboxylic acid cycle Effects 0.000 description 1
208000003982 trichinellosis Diseases 0.000 description 1
201000007588 trichinosis Diseases 0.000 description 1
208000009920 trichuriasis Diseases 0.000 description 1
102000015533 trkA Receptor Human genes 0.000 description 1
108010064884 trkA Receptor Proteins 0.000 description 1
201000002311 trypanosomiasis Diseases 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
208000009999 tuberous sclerosis Diseases 0.000 description 1
206010061393 typhus Diseases 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
230000035899 viability Effects 0.000 description 1
201000002498 viral encephalitis Diseases 0.000 description 1
201000010044 viral meningitis Diseases 0.000 description 1
208000009421 viral pneumonia Diseases 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
201000007790 vitelliform macular dystrophy Diseases 0.000 description 1
230000004580 weight loss Effects 0.000 description 1